l-carnitine tmao koeth 2013 nature medicine Trimethylamine N-Oxide in Relation to Cardiometabolic Health—Cause or Effect? γ–Butyrobetaine is a pro-atherogenic intermediate

Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC The gutbrain axis and trimethylamine N oxide: an emergent biomarker in neurological diseases ScienceDirect Gut Metabolite Trimethylamine N Oxide in Atherosclerosis: From Mechanism to Therapy Frontiers Dietary allicin reduces transformation of L carnitine to TMAO through impact on gut microbiota ScienceDirect

SKU: 63749192244 · From webdevsolutions.tech